Germ Cell Tumor
📧 Sign up to get email alerts when something new happens for Germ Cell Tumor.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Tumor-Lymph Node Mapping
Clinical trial from the University of Rochester is actively recruiting to study tumor-lymph node mapping in pediatric solid tumors. The cond…
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies [Phase 1]
Phase 1 trial at New York Medical College evaluating vorinostat in combination with chemotherapy for relapsed/refractory solid tumors and CN…
-
CLINICAL_TRIALS research · 2026-04-14Clinical Trial Update: A Study of ZW251 in Participants With Advanced Solid Tumors [Phase 1]
This Phase 1 trial update notes a study of ZW251 in participants with advanced solid tumors, including hepatocellular carcinoma, non-small c…
-
CLINICAL_TRIALS research · 2026-04-07Clinical Trial Update: Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors [Phase 3]
A Phase 3 clinical trial update on active surveillance followed by BEP-like regimens (bleomycin, etoposide, with carboplatin or cisplatin) i…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study to Test How Well Different Doses of BI 3820768 Are Tolerated by People With Advanced Cancer (Solid Tumours) [Phase 1]
A Phase 1 trial to assess tolerability of different doses of BI 3820768 in adults with advanced relapsed or refractory germ cell tumors, end…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors [Phase 1]
Phase 1 safety and tolerability study of XmAb541 in advanced solid tumors is currently recruiting, investigating ovarian cancer, endometrial…
-
CLINICAL_TRIALS research · 2026-03-12Clinical Trial Update: A Study of miRNA 371 in Patients With Germ Cell Tumors
SWOG Cancer Research Network is studying miRNA-371 in patients with germ cell tumors; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Proton Beam Radiation Therapy for Central Nervous System (CNS) Germ Cell Tumors [NA]
This clinical trial update concerns proton beam radiation therapy for central nervous system germ cell tumors. Sponsored by Massachusetts Ge…
-
CLINICAL_TRIALS research · 2026-02-04Clinical Trial Update: Germ Cell Tumor and Testicular Tumor DNA Registry
This entry describes a Germ Cell Tumor and Testicular Tumor DNA Registry clinical trial, currently recruiting at Memorial Sloan Kettering Ca…
-
CLINICAL_TRIALS research · 2026-02-02Clinical Trial Update: A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy [Phase 2]
A single-arm Phase II trial evaluating aspirin for prevention of venous thromboembolism in patients with advanced germ cell tumors receiving…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Evaluating Immune Therapy, Duravalumab (MEDI4736) With Tremelimumab for Relapsed/Refractory Germ Cell Tumors [Phase 2]
Phase 2 clinical trial evaluating the combination of durvalumab and tremelimumab for relapsed/refractory germ cell tumors; the study is curr…
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors [Phase 2]
Status update on a Phase 2 trial of nivolumab plus ipilimumab for advanced rare genitourinary tumors; the study is currently active but not …
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Phase II Trial of Cabozantinib With Patients With Refractory GCTs [Phase 2]
Update on a Phase II trial of cabozantinib in patients with refractory germ cell tumors.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: HER2-specific CAR T Cell Locoregional Immunotherapy for HER2-positive Recurrent/Refractory Pediatric CNS Tumors [Phase 1]
Phase 1 trial evaluating locoregional HER2-targeted CAR T-cell therapy for pediatric recurrent or refractory central nervous system tumors a…
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Observational Study for Assessing Treatment and Outcome of Patients With Primary Brain Tumours Using cIMPACT-NOW and 2021 WHO Classification
This clinical trial update describes an observational study by the EORTC to assess treatment patterns and outcomes for patients with primary…
-
CLINICAL_TRIALS research · 2025-11-21Clinical Trial Update: Maintenance Zanzalintinib With Etoposide After HDCT in GCT [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating maintenance zanzalintinib with etoposide after high-dose chemotherapy in germ cell tumors; currently r…
-
CLINICAL_TRIALS research · 2025-10-24Clinical Trial Update: Molecular Epidemiology of Pediatric Germ Cell Tumors
A pediatric clinical trial by the Children's Oncology Group to study the molecular epidemiology of germ cell tumors and their histologic sub…
-
CLINICAL_TRIALS research · 2025-09-23Clinical Trial Update: Treatment of Newly Diagnosed Central Malignant Germ Cell Tumor People With Teniposide Injection Combined With Cisplatin. [Phase 2]
Phase 2 trial update evaluating teniposide with cisplatin for newly diagnosed Central Malignant Germ Cell Tumor, with recruitment ongoing.
-
CLINICAL_TRIALS research · 2025-08-13Clinical Trial Update: Dornase Alfa and Cisplatin in Refractory Germ Cell Cancer. [Phase 2]
A Phase 2 clinical trial evaluating the combination of Dornase alfa and cisplatin for refractory germ cell tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-08-03Clinical Trial Update: High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors [Phase 2]
Phase 2 clinical trial evaluating high-dose chemotherapy as second-line therapy for relapsed germ cell tumors; the study is currently recrui…
-
CLINICAL_TRIALS research · 2025-07-29Clinical Trial Update: Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers [NA]
A multi-cancer prospective study evaluating double-positive circulating cells (CD45+ tumor marker) in several types of metastatic cancers; r…
-
CLINICAL_TRIALS research · 2025-07-11Clinical Trial Update: Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling [Phase 1]
Phase 1 clinical trial evaluating ex vivo drug sensitivity testing and multi-omics profiling in pediatric cancers. Recruitment is ongoing ac…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Accelerated v's Standard BEP Chemotherapy for Patients With Intermediate and Poor-risk Metastatic Germ Cell Tumours [Phase 3]
A Phase 3 trial comparing accelerated versus standard BEP chemotherapy for intermediate- and poor-risk metastatic germ cell tumors is curren…
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: Thromboprophylaxis in Good and Intermediate Prognosis Advanced Germ Cell Tumors [Phase 3]
Ongoing Phase 3 study evaluating thromboprophylaxis in good and intermediate prognosis advanced germ cell tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2025-04-18Clinical Trial Update: Maintenance Oral Etoposide or Observation Following High-dose Chemo for GCT [Phase 2]
A Phase 2 trial is evaluating maintenance oral etoposide after high-dose chemotherapy for germ cell tumors. The study compares maintenance t…